心肌血流量定量对心脏移植物血管病的诊断与预后价值
本研究纳入94例原位心脏移植受者,其中66例在1年内接受有创冠状动脉造影和PET检查,评估心肌血流量(MBF)定量在标准PET心肌灌注显像基础上对心脏移植物血管病(CAV)的附加诊断和预后价值。结果显示,加入LVEF和负荷MBF后,检测中重度CAV的特异度和阳性预测值提高,ROC面积从0.82增至0.88(P=0.01),且PET CAV分级与主要不良事件年化发生率相关。
要点
- 在标准PET灌注显像基础上加入负荷MBF和LVEF可提高检测中重度CAV的特异度和阳性预测值。
- PET CAV分级正常、轻度、中重度异常的患者年化事件率分别为5%、9%、25%(P<0.001)。
- 多参数心脏PET评估可改善CAV严重程度的检测和分级,并预测主要不良事件。
核心结论
- 多参数心脏PET评估包括MBF定量,较标准心肌灌注评估改善了CAV严重程度的检测和分级,并可预测主要不良事件。
研究设计与样本
- 研究纳入94例原位心脏移植受者(预后队列),其中66例在1年内接受有创冠状动脉造影和PET检查(诊断队列)。
- 以ISHLT分类作为CAV的标准定义,PET评估包括半定量MPI、定量MBF(mL/min/g)和LVEF,并基于ISHLT标准构建PET CAV严重程度评分(0-3分)。
- 患者随访中位时间2.3年,观察主要不良事件(死亡、再移植、急性冠脉综合征和心力衰竭住院)。
主要发现
- 半定量PET灌注单独检测中重度CAV的敏感度、特异度、阳性预测值和阴性预测值分别为83% [52-98]、82% [69-91]、50% [27-73]和96% [85-99],ROC面积0.82 [0.70-0.95]。
- 加入LVEF和负荷MBF后,上述值分别为83% [52-98]、93% [82-98]、71% [42-92]和96% [97-99],ROC面积0.88 [0.76-0.99](P=0.01)。
- 随访期间发生20例主要不良事件,PET CAV分级正常、轻度和中重度异常的患者年化事件率分别为5%、9%和25%(P<0.001)。
临床怎么用
- 对于心脏移植受者,可考虑采用多参数心脏PET评估(包括MBF定量和LVEF)进行CAV的无创筛查和危险分层。
- PET CAV分级中重度异常提示主要不良事件风险显著升高,可能需要加强监测和干预。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS: Cardiac allograft vasculopathy (CAV) is a leading cause of death in orthotopic heart transplant (OHT) survivors. Effective non-invasive screening methods are needed. Our aim was to investigate the added diagnostic and prognostic value of myocardial blood flow (MBF) to standard myocardial perfusion imaging (MPI) with positron emission tomography (PET) for CAV detection. METHODS AND RESULTS: We studied 94 OHT recipients (prognostic cohort), including 66 who underwent invasive coronary angiography and PET within 1 year (diagnostic cohort). The ISHLT classification was used as standard definition for CAV. Positron emission tomography evaluation included semiquantitative MPI, quantitative MBF (mL/min/g), and left ventricular ejection fraction (LVEF). A PET CAV severity score (on a scale of 0-3) was modelled on the ISHLT criteria. Patients were followed for a median of 2.3 years for the occurrence of major adverse events (death, re-transplantation, acute coronary syndrome, and hospitalization for heart failure). Sensitivity, specificity, positive, and negative predictive value of semiquantitative PET perfusion alone for detecting moderate-severe CAV were 83% [52-98], 82% [69-91], 50% [27-73], and 96% [85-99], respectively {receiver operating characteristic (ROC area: 0.82 [0.70-0.95])}. These values improved to 83% [52-98], 93% [82-98], 71% [42-92], and 96% [97-99], respectively, when LVEF and stress MBF were added (ROC area: 0.88 [0.76-0.99]; P = 0.01). There were 20 major adverse events during follow-up. The annualized event rate was 5%, 9%, and 25% in patients with normal, mildly, and moderate-to-severely abnormal PET CAV grading (P < 0.001), respectively. CONCLUSION: Multiparametric cardiac PET evaluation including quantification of MBF provides improved detection and gradation of CAV severity over standard myocardial perfusion assessment and is predictive of major adverse events.
引用
- Bravo PE, Bergmark BA, Vita T, et al. Diagnostic and prognostic value of myocardial blood flow quantification as non-invasive indicator of cardiac allograft vasculopathy. Eur Heart J. 2018. PMID: 29236988. doi:10.1093/eurheartj/ehx683
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。